Innovative medical products and regulatory pathways to market

These proposals provide clear, risk-proportionate, efficient and internationally harmonised regulatory pathways under the Medical Products Bill for:

• innovative medical products (through regulatory and financial incentives to encourage product development and access for patients in New Zealand), and
• software and artificial intelligence intended for a therapeutic purpose (software-as-a medical device).